This study investigated  the performance of ART eligibility criteria in pregnant and postpartum women in resource-limited settings, and found that use of CD4+ cell count criterion is superior to clinical staging in identifying pregnant and postpartum HIV+ women eligible for ART.

 

The original article by Carter et al. (2010) is located online in the Journal of Acquired Immune Deficiency Syndromes at: http://journals.lww.com/jaids/Fulltext/2010/11010/CD4__Cell_Count_Testing_More_Effective_Than_HIV.19.aspx

Categories

Resources  Tests  

Tags

ART  CD4  HIV  

Reply

Please Sign in (or Register) to view further.